Publication:
Prescribing trends in treatment-resistant schizophrenia

Simple item page
dc.contributor.authorGÖRMEZ, AYNUR
dc.contributor.authorKURTULMUŞ, AYŞE
dc.contributor.authorTuncer, Can
dc.contributor.authorÇıtak, Serhat
dc.contributor.institutionauthorKURTULMUŞ, AYŞE
dc.date.accessioned2020-10-29T14:58:43Z
dc.date.available2020-10-29T14:58:43Z
dc.date.issued2017-01-01T00:00:00Z
dc.description.abstractObjectives: Schizophrenia is a common mental health condition associated with significant morbidity and excess early mortality. Treatment-resistant schizophrenia (TRS) occurs in about one in three patients diagnosed with schizophrenia. The aim of this study was to identify attitudes of a nationally representative sample of psychiatrists towards pharmacotherapy of patients with TRS, the potential factors related to their choice of various regimens, and to investigate the clinical outcomes of different methods employed.
dc.identifier.citationGÖRMEZ A., KURTULMUŞ A., Tuncer C., Çıtak S., -Prescribing trends in treatment-resistant schizophrenia-, PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.27, ss.419-426, 2017
dc.identifier.doi10.1080/24750573.2017.1370767
dc.identifier.scopus85047607435
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25537
dc.identifier.wosWOS:000422640800018
dc.titlePrescribing trends in treatment-resistant schizophrenia
dc.typeArticle
dspace.entity.typePublication
local.avesis.id3259f132-e6e1-4669-a22d-16c6c77fb44e
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication872bdd44-052f-431c-919a-72a52d37ec2d
relation.isAuthorOfPublication.latestForDiscovery872bdd44-052f-431c-919a-72a52d37ec2d
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Yayınlar - Eserler